Frailty is Associated with Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation.
Frailty, a state of decreased physiologic reserve, has been associated with dysregulation of the immune system. We hypothesized that frailty is associated with differential rates of acute cellular rejection (ACR) in LT recipients. Included were LT recipients from 2014-16 who had a pre-LT frailty assessment using the Liver Frailty index (LFI). Frailty was defined as a LFI ≥ 4.5. ACR at 3 months was ascertained from pathology reports and immunosuppression regimens were collected from chart review. 241 LT recipients were included: 46 (19%) were classified as frail pre-LT. Median tacrolimus trough levels, mycophenolate doses, and corticosteroid doses at discharge and 3-months were similar between frail and non-frail patients. Within 3 months post-LT, 7 (15%) frail patients versus 10 (5%) non-frail patients experienced ACR (p=0.02). In univariable analysis, frailty was associated with a 3.3 times higher odds of ACR at 3 months (95% CI 1.2, 9.3, p=0.02). Bivariable analyses was conducted with co-variates that were associated with acute cellular rejection in univariable analysis or have been previously associated with either frailty (age, female sex) or acute cellular rejection (MELD, ascites), as well as relevant immunosuppression variables. In bivariable analysis, frailty remained significantly associated with acute cellular rejection at 3 months with an odds ratio relatively similar to the unadjusted value. In conclusion, frailty is associated with an increased rate of ACR within 3 months, despite similar immunosuppression regimens, suggesting that frailty should be considered in immediate post-LT management.